About 29,343 results

ALLMedicine™ Venous Thromboembolism Center

Research & Reviews  9,350 results

Pathological Analysis and Clinical Evolution After Radiological Removal of Retrievable ...
Vascular and Endovascular Surgery; Annweiler T, Bertoletti L et. al.

Aug 16th, 2022 - Retrievable inferior vena cava filters (IVCF) have been developed because permanent filters have been associated with an increased risk of recurrent deep venous thrombosis. There is no data on the interactions of IVCF with the inferior vena cava (...

Trends in post-discharge prophylactic anticoagulant use among stroke patients in the Un...
Journal of Stroke and Cerebrovascular Diseases : the Offi... Dawwas GK, Cuker A et. al.

Aug 15th, 2022 - Stroke is an independent risk factor for venous thromboembolism (VTE). Although the risk of VTE persists after hospital discharge, information on the utilization of anticoagulants among stroke patients after discharge remains limited. To evaluate ...

Thromboembolism and bleeding in patients with autoimmune blistering disease.
Clinical and Experimental Dermatology; Sho Y, Sakai T et. al.

Aug 14th, 2022 - The prevention and early detection of venous thromboembolism (VTE), including pulmonary thromboembolism (PE), is essential in daily medical practice. We had previously reported the risk of VTE in patients with autoimmune blistering disease. Moreov...

Venous Thromboembolism in Cancer and Cancer Immunotherapy.
Critical Reviews in Oncology/hematology; Kacimi SEO, Moeinafshar A et. al.

Aug 13th, 2022 - Venous thromboembolism (VTE) is a clinical disease that includes deep vein thrombosis and pulmonary embolism. Amongst its underlying risk factors, cancer is of great importance. Stasis, endothelial injury, and hypercoagulability result in clot for...

Antiphospholipid Antibodies in Patients with Calcific Aortic Valve Stenosis.
Rheumatology (Oxford, England); Plunde O, Svenungsson E et. al.

Aug 13th, 2022 - The antiphospholipid syndrome is defined by antiphospholipid antibodies (aPL) together with arterial and/or venous thromboembolism and/or obstetric morbidities. aPL are overrepresented in systemic lupus erythematosus (SLE) and acute myocardial inf...

see more →

Guidelines  55 results

American Society of Hematology living guidelines on the use of anticoagulation for thro...
Blood Advances; Cuker A, Tseng EK et. al.

Nov 3rd, 2021 - COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care pr...

American Society of Hematology living guidelines on the use of anticoagulation for thro...
Blood Advances; Cuker A, Tseng EK et. al.

Sep 3rd, 2021 - COVID-19-related critical illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care...

A modeling approach to derive baseline risk estimates for GRADE recommendations: Concep...
Journal of Clinical Epidemiology; Morgano GP, Wiercioch W et. al.

Jul 21st, 2021 - The goal of this study was to develop an approach that can be used where baseline risk estimates that are directly applicable to prioritized patient-important outcomes are not available from published studies. The McMaster University GRADE Centre ...

American Society of Hematology 2021 guidelines for management of venous thromboembolism...
Blood Advances; Lyman GH, Carrier M et. al.

Feb 12th, 2021 - Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. These evidence-based guidelines of the American Society of Hematology (ASH...

Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncolog...
Gynecologic Oncology; Gressel GM, Marcus JZ et. al.

Dec 2nd, 2020 - Venous thromboembolism (VTE) is a common cause of morbidity and mortality in women with gynecologic malignancies. This practice statement provides clinical data and overall quality of evidence regarding the use of direct oral anticoagulants (DOACs...

see more →

Drugs  18 results see all →

Clinicaltrials.gov  682 results

Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics

Aug 12th, 2022 - Hospitalized children frequently require a vascular access device (VAD) for delivery of life saving interventions such as intravenous fluids and antibiotics. Peripherally Inserted Central Catheters (PICCs) are central VADs frequently used in hospi...

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Aug 11th, 2022 - This is an observational study in which data from the past is collected for a treatment which is already available for doctors to prescribe for venous thromboembolism (VTE). VTE is a condition in which blood clots form in veins, which can lead to ...

Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

Aug 11th, 2022 - Although acute myocardial infarction (AMI) is more common in the elderly, its incidence in young patients is increasing. The exact pathogenetic mechanism of AMI in young patients remains largely unknown and involves the interaction of multiple gen...

Predicting the Risk of Venous Thromboembolism in Critically Ill Patients

Aug 11th, 2022 - Objective To perform external validation of existing prediction models (phase 1) To develop and internally validate a model for predicting the risk of in-hospital VTE in critically ill patients (phase 2) Study design: Our objectives will require a...

Soft Robotic Sock Intervention for Robot-assisted Ankle-foot Mobility in Post-stroke Patients

Aug 10th, 2022 - Stroke is one of the top medical conditions resulting in high mortality among patients in hospitals, where complications related to immobility such as deep vein thrombosis (DVT) and/or ankle joint contracture can affect patients in their road to r...

see more →

News  1,630 results

New Biomarker Flags VTE Risk in COVID-19 Patients

Aug 16th, 2022 - Elevated levels of soluble urokinase plasminogen activator receptor (suPAR) — a protein produced by the immune system in response to SARS-CoV-2 infection — may predict the formation of clots in patients hospitalized with COVID-19, even those with ...

Updates on Treatment/Prevention of VTE in Cancer Patients

Aug 8th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Updated clinical practice guidelines for the treatment and prevention of venous thromboembolism (VTE) for patients with cancer, including those wi...

RV Dysfunction Slams Survival in Acute COVID, Flu, Pneumonia

Jul 18th, 2022 - The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Right ventricular (RV) dilation or dysfunction in patients hospitalized with acute COVID-19 is associated with an elevat...

Appropriateness of Pharmacologic Thromboprophylaxis Prescribing Based on Padua Score Among Inpatient Veterans
Bianca Creith, PharmD, BCPS, Gabrielle Givens, PharmD, BCPS et. al.

Jul 1st, 2022 - Venous thromboembolism (VTE) presents as deep venous thromboembolism (DVT) or pulmonary embolism (PE). VTE is the third most common vascular disease and a leading cardiovascular complication.

Case study: Managing venous thromboembolism in the cancer patient
David H. Henry, MD

May 31st, 2022 - A 75-year-old male is seen in the emergency department for shortness of breath. D-dimer is very high, and a CT scan chest reveals bilateral pulmonary emboli without right heart strain.

see more →

Patient Education  2 results see all →